We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Three More Drug Industry Execs Face Congressional Grilling Over Price Hikes
Three More Drug Industry Execs Face Congressional Grilling Over Price Hikes
Responding to charges that the justifications for dramatic drug price increases to fuel expenses are “baseless,” the heads of Amgen, Mallinckrodt and Novartis told lawmakers Thursday they are willing to pull back in some instances on continuing steep price hikes.